Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Felipe Ades
Targeting the Cellular Signaling: BRAF Inhibition and Beyond for the Treatment of Metastatic Malignant Melanoma
Dermatology Research and Practice
Dermatology
Related publications
Correction: Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
PLoS ONE
Multidisciplinary
Malignant Melanoma Metastatic to the Larynx: Treatment and Functional Outcome
Current Oncology
Oncology
Beyond BRAF: Where Next for Melanoma Therapy?
British Journal of Cancer
Cancer Research
Oncology
Targeting Epigenetics for Treatment of BRAF Mutated Metastatic Melanoma With Decitabine in Combination With Vemurafenib: A Phase Lb Study
Oncotarget
Oncology
Targeting Metastatic Melanoma
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Metastatic Malignant Melanoma of the Gastric Mucosa
Internal Medicine
Internal Medicine
Medicine
An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin
Clinical Medicine Insights: Dermatology
Melatonin Synergizes BRAF-targeting Agent Vemurafenib in Melanoma Treatment by Inhibiting iNOS/hTERT Signaling and Cancer-Stem Cell Traits
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Two Cases of Metastatic Malignant Melanoma
Japanese Journal of Neurosurgery
Surgery
Neurology